Skip to main content
. 2023 Sep 22;102(38):e34730. doi: 10.1097/MD.0000000000034730

Table 1.

Characteristics of the patients in our study cohort.

Number of patients = 11
Age (yr, ± SD) 61.9 ± 18.9
Sex (female/male) 9/2
BMI (kg/m2, ± SD) 26.7 ± 5.2
Hormonal deficiencies
 Deficiency of ACTH (%) 54.5
 Deficiency of TSH (%) 54.5
 Deficiency of LH (%) 45.5
 Deficiency of FSH (%) 45.5
 Central diabetes insipidus (%) 9.1
 Deficiency of GH (%) 100
Replacement therapies
 Hydrocortisone (%) 54.5
 Levothyroxine (%) 63.6#
 HCG/HMG (%) 0
 Testosterone/estradiol (%) 0
 Desmopressin (%) 9.1
 GH (%) 100
Periods of GH replacement therapy (yr, ± SD) 6.9 ± 2.9

ACTH = adrenocorticotropic hormone, FSH = follicle-stimulating hormone, GH = growth hormone, HCG = human chorionic gonadotrophin, HMG = human menopausal gonadotropin, LH = luteinizing hormone, TSH = thyroid-stimulating hormone.

#One patient took levothyroxine for primary hypothyroidism.